GCMG Valuation
GCM Grosvenor Inc
$
12.530
- Overview
- Forecast
- Valuation
GCMG Relative Valuation
GCMG's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, GCMG is overvalued; if below, it's undervalued.
Historical Valuation
No Data
Competitors Valuation Multiple
The average P/S ratio for GCMG's competitors is 4.30, providing a benchmark for relative valuation. GCM Grosvenor Inc Corp (GCMG) exhibits a P/S ratio of 1.20, which is -72.13% above the industry average. Given its robust revenue growth of 15.60%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
People Also Watch
ARWR
Arrowhead Pharmaceuticals Inc
16.350
USD
+0.37%
HNI
HNI Corp
46.740
USD
-1.14%
MPW
Medical Properties Trust Inc
4.817
USD
-2.09%
SPNT
Siriuspoint Ltd
19.545
USD
+0.13%
FBK
FB Financial Corp
44.650
USD
-1.54%
MTX
Minerals Technologies Inc
59.205
USD
-0.78%
ICFI
ICF International Inc
86.980
USD
-1.68%
RPD
Rapid7 Inc
22.815
USD
-2.33%
ADUS
Addus Homecare Corp
111.825
USD
-0.61%
WULF
Terawulf Inc
3.935
USD
+0.38%
FAQ
Is GCM Grosvenor Inc (GCMG) currently overvalued or undervalued?
GCM Grosvenor Inc (GCMG) is now in the Fair zone, suggesting that its current forward PE ratio of 17.58 is considered Fairly compared with the five-year average of 16.40. The fair price of GCM Grosvenor Inc (GCMG) is between 10.05 to 14.43 according to relative valuation methord.
What is GCM Grosvenor Inc (GCMG) fair value?
How does GCMG's valuation metrics compare to the industry average?
What is the current P/B ratio for GCM Grosvenor Inc (GCMG) as of May 21 2025?
What is the current FCF Yield for GCM Grosvenor Inc (GCMG) as of May 21 2025?
What is the current Forward P/E ratio for GCM Grosvenor Inc (GCMG) as of May 21 2025?